blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3360581

EP3360581 - PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING INHIBITOR OF PLRG1 (PLEIOTROPIC REGULATOR 1) AS ACTIVE INGREDIENT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  15.08.2024
Database last updated on 03.09.2024
FormerExamination is in progress
Status updated on  20.06.2020
FormerRequest for examination was made
Status updated on  13.07.2018
FormerThe international publication has been made
Status updated on  18.04.2017
Most recent event   Tooltip15.08.2024Application deemed to be withdrawnpublished on 18.09.2024 [2024/38]
Applicant(s)For all designated states
Korea Institute of Radiological & Medical Sciences
75 Nowon-ro
Nowon-gu
Seoul 01812 / KR
[2018/33]
Inventor(s)01 / LEE, Kee-Ho
603-403
71 Sirubong-ro
Dobong-gu
Seoul 01374 / KR
02 / KIM, Sungsub
307-1404
448 Expo-ro
Yuseong-gu
Daejeon 34049 / KR
03 / KIM, Yeon-Soo
1111ho
11 Gyeryong-ro 52beon-gil
Yuseong-gu
Daejeon 34178 / KR
04 / PARK, Eun-Ran
103-408
19 Gongneung-ro 46-gil
Nowon-gu
Seoul 01813 / KR
05 / SHIN, Hyun Jin
108-101
10 Cheonho-daero 199-gil
Gangdong-gu
Seoul 05348 / KR
06 / LEE, Eun-Ju
103-701
7 Baekjegobun-ro 18-gil
Songpa-gu
Seoul 05577 / KR
07 / HAM, Yong-Ho
12 Suraksan-ro 6-gil
Nowon-gu
Seoul 05577 / KR
08 / KIM, Sang Bum
107-1202
14 Ichon-ro 87-gil
Yongsan-gu
Seoul 04424 / KR
09 / PARK, Sun-Hoo
1401-1202
537-17 Achasan-ro
Gwangjin-gu
Seoul 04983 / KR
10 / HAN, Chul-Ju
B-2503
235 Toegye-ro
Jung-gu
Seoul 04558 / KR
11 / HONG, Sung Hee
101-1402
32 Dobong-ro 180ga-gil
Dobong-gu
Seoul 01318 / KR
12 / KIM, Yang Hyun
303ho
53-46 Dongil-ro 186-gil
Nowon-gu
Seoul 01843 / KR
13 / KIM, Jung Min
502ho
170-2 Galhyeon-ro
Eunpyeong-gu
Seoul 03410 / KR
14 / KIM, Mi Yeun
113-705
165 Buyeong-ro
Bupyeong-gu
Incheon 21377 / KR
15 / KANG, Moonkyoung
106-604
65 Gajeong-ro
Yuseong-gu
Daejeon 34120 / KR
16 / SONG, Eun Yeong
205-502
35 Yongjeong-ro
Sangdang-gu
Cheongju-si Chungcheongbuk-do 28748 / KR
17 / SONG, Jie Young
10, Yeouidong-ro 3-gil
Yeongdeungpo-gu
Seoul 07324 / KR
 [2018/33]
Representative(s)Gassner, Birgitta, et al
REDL Life Science Patent Attorneys
Donau-City-Straße 11
1220 Wien / AT
[2018/33]
Application number, filing date16853944.307.10.2016
[2018/33]
WO2016KR11272
Priority number, dateKR2015014166708.10.2015         Original published format: KR 20150141667
[2018/33]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017061828
Date:13.04.2017
Language:KO
[2017/15]
Type: A1 Application with search report 
No.:EP3360581
Date:15.08.2018
Language:EN
[2018/33]
Search report(s)International search report - published on:KR13.04.2017
(Supplementary) European search report - dispatched on:EP06.05.2019
ClassificationIPC:C12N15/113, A61K48/00, A61K39/395
[2022/02]
CPC:
C12N15/1135 (EP,US); A61K48/00 (EP,KR,US); A61K39/395 (EP,KR,US);
A61K39/39558 (KR); A61P35/00 (EP,US); C12N15/1138 (EP,US);
G01N33/57496 (US); C12N2310/11 (EP,US); C12N2310/14 (EP,US);
C12N2310/531 (EP,US); C12N2320/30 (EP,US); C12N2330/30 (US) (-)
Former IPC [2019/23]A61K48/00, A61K39/395, C12N15/113
Former IPC [2018/33]A61K48/00, A61K39/395
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/33]
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR PRÄVENTION ODER BEHANDLUNG VON KREBS MIT INHIBITOR VON PLRG1 (PLEIOTROPER REGULATOR 1) ALS WIRKSTOFF[2018/33]
English:PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING INHIBITOR OF PLRG1 (PLEIOTROPIC REGULATOR 1) AS ACTIVE INGREDIENT[2018/33]
French:COMPOSITION PHARMACEUTIQUE POUR PRÉVENIR OU TRAITER UN CANCER COMPRENANT UN INHIBITEUR DE PLRG1 (RÉGULATEUR PLÉIOTROPIQUE 1) COMME PRINCIPE ACTIF[2018/33]
Entry into regional phase08.05.2018Translation filed 
08.05.2018National basic fee paid 
08.05.2018Search fee paid 
08.05.2018Designation fee(s) paid 
08.05.2018Examination fee paid 
Examination procedure08.05.2018Examination requested  [2018/33]
08.05.2018Date on which the examining division has become responsible
21.11.2019Amendment by applicant (claims and/or description)
24.06.2020Despatch of a communication from the examining division (Time limit: M06)
04.01.2021Reply to a communication from the examining division
12.01.2022Despatch of a communication from the examining division (Time limit: M06)
21.07.2022Reply to a communication from the examining division
01.05.2024Application deemed to be withdrawn, date of legal effect  [2024/38]
24.05.2024Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2024/38]
Fees paidRenewal fee
08.05.2018Renewal fee patent year 03
25.10.2019Renewal fee patent year 04
30.10.2020Renewal fee patent year 05
25.10.2021Renewal fee patent year 06
25.10.2022Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.10.202308   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]WO02095417  (UNIV DUNDEE [GB], et al) [X] 1,6,8 * the whole document * [I] 2,7;
 [X]  - A. KLEINRIDDERS ET AL., "PLRG1 is an essential regulator of cell proliferation and apoptosis during vertebrate development and tissue homeostasis", MOLECULAR AND CELLULAR BIOLOGY, (20090601), vol. 29, no. 11, doi:10.1128/MCB.01807-08, ISSN 0270-7306, pages 3173 - 3185, XP055373922 [X] 9 * the whole document *

DOI:   http://dx.doi.org/10.1128/MCB.01807-08
International search[XA]CN1328026  (BODE GENE DEV CO LTD SHANGHAI [CN]) [X] 1-3, 6-7, 9-13 * See instructions 2-3, 14, 16-18. * [A] 4-5;
 [XA]CN1333240  (BODE GENE DEV CO LTD SHANGHAI [CN]) [X] 1-3, 6-7, 9-13 * See instructions 2-3, 14, 16-8. * [A] 4-5;
 [A]US2004253646  (LAMOND ANGUS IAIN [GB], et al) [A] 1-7, 9-13 * See claims 1-26. *;
 [A]KR20100018237  (KOREA INST SCI & TECH [KR]) [A] 1-7, 9-13* See claims 1, 4-6. *;
 [A]  - KLEINRIDDERS, A. et al., "PLRG1 Is an Essential Regulator of Cell Proliferation and Apoptosis during Vertebrate Development and Tissue Homeostasis", Molecular and Cellular Biology, (20090000), vol. 29, no. 11, pages 3173 - 3185, XP055373922 [A] 1-7, 9-13 * , See page 3173. *

DOI:   http://dx.doi.org/10.1128/MCB.01807-08
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.